Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. JJDC typically makes an initial investment up to $5 million, targeting the geographies of North America, Europe and Israel. Johnson & Johnson Development Corporation's (JJDC) investments range from the early stages of seed funding to the advanced stages of series venture management. The fund amount of an investment depends upon the stage of funding, phase of product development, and alignment of the business venture with JJDC strategic growth objectives.